Stocksigma LogoStocksigma Logo

Jubilant Pharmova Board Approves ₹800 Crore NCD Issuance and ₹2,500 Crore Borrowing Limit

Jubilant Pharmova's board approved the private placement of up to 80,000 listed, rated, redeemable NCDs (face value ₹1,00,000 each) aggregating up to ₹800

Jubilant Pharmova Board Approves ₹800 Crore NCD Issuance and ₹2,500 Crore Borrowing Limit

Jubilant Pharmova Ltd · Outcome · 12 Oct 2026, 6:05 pm

Jubilant Pharmova Board Approves ₹800 Crore NCD Issuance and ₹2,500 Crore Borrowing Limit Jubilant Pharmova's board approved the private placement of up to 80,000 listed, rated, redeemable NCDs (face value ₹1,00,000 each) aggregating up to ₹800 crore across multiple tranches with a tenure of up to five years, to be listed on BSE. Additionally, the board is seeking shareholder approval via postal ballot to issue non-convertible debt securities on a private placement basis for an aggregate outstanding amount of up to ₹2,500 crore over a one-year period. Coupon rates will be determined via bidding.

Original exchange filing (PDF)

More announcements from Jubilant Pharmova Ltd

All Jubilant Pharmova Ltd announcements